Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dynavax Technologies
(NQ:
DVAX
)
11.21
+0.04 (+0.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dynavax Technologies
< Previous
1
2
3
4
5
6
Next >
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
February 22, 2024
DVAX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Dynavax Technologies: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Why Vera Therapeutics Stock Soared by 22% This Week
January 12, 2024
Executive changes and a bullish analyst take combined to boost sentiment on the company.
Via
The Motley Fool
3 Stocks Set to Soar 68% to 200% Higher
January 08, 2024
Analyst stock picks for outsized growth potential mean these companies should handily outperform the market averages.
Via
InvestorPlace
Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript
November 03, 2023
DVAX earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Preview For Dynavax Technologies
November 01, 2023
Via
Benzinga
Preview: Dynavax Technologies's Earnings
August 02, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
May 29, 2023
Via
Benzinga
The Latest Analyst Ratings for Dynavax Technologies
May 03, 2023
Via
Benzinga
Dynavax Technologies's Return On Capital Employed Insights
March 01, 2023
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why
September 07, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Restaurant Brands International Inc. (NYSE: QSR) is a buy.
Via
Benzinga
JMP Securities Maintains Market Outperform Rating for Dynavax Technologies: Here's What You Need To Know
February 24, 2023
Via
Benzinga
Dynavax Technologies Stock Sees Renewed Technical Strength
August 07, 2023
Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.
Via
Investor's Business Daily
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
August 04, 2023
DVAX earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Overview Of Value Stocks In The Healthcare Sector
July 31, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
July 24, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
July 17, 2023
Via
Benzinga
The 7 Best Stocks Under $15 to Buy in June 2023
June 01, 2023
While you generally get what you pay for, these best stocks under $15 for June provide compelling opportunities at discount.
Via
InvestorPlace
Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript
May 02, 2023
DVAX earnings call for the period ending March 31, 2023.
Via
The Motley Fool
7 Biotech Stocks Sitting in the Sweet Spot
March 24, 2023
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.
Via
InvestorPlace
The Top 7 Growth Stocks in Biotech
March 03, 2023
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.
Via
InvestorPlace
Dynavax Technologies (DVAX) Q4 2022 Earnings Call Transcript
February 23, 2023
DVAX earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Jim Cramer On This Stock Up 2% Over 6 Months: 'You've Got A Real Winner There'
January 20, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Weyerhaeuser Co (NYSE: WY) a lot.
Via
Benzinga
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
January 15, 2023
From
Clover Biopharmaceuticals
Via
GlobeNewswire
The 7 Most Undervalued Long-Term Stocks to Buy in January
January 14, 2023
Investors should keep an eye on these severely undervalued long-term stocks as we get deeper into New Year 2023.
Via
InvestorPlace
Our 7 Top Small-Cap Stock Picks for 2023
December 12, 2022
Most of the names on this list of small-cap stock picks for 2023 are ready to rebound from a tough year in the markets.
Via
InvestorPlace
Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
November 30, 2022
Via
Benzinga
Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases
November 30, 2022
From
Clover Biopharmaceuticals
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.